Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial

Akman A. O., Kara F. K., Koksal T., Cakir B., Karagol C., Sayli T.

TRANSFUSION AND APHERESIS SCIENCE, cilt.56, sa.4, ss.531-534, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.transci.2017.07.022
  • Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.531-534
  • Anahtar Kelimeler: Hemolysis, Infusion, Intravenous immunoglobulin, Pediatric, ANTI-A, KAWASAKI-DISEASE, IMMUNE GLOBULIN, DISORDERS, TRANSFUSION, AUTOIMMUNE, MECHANISMS, PRODUCTS
  • Gazi Üniversitesi Adresli: Hayır

Özet

lmmunoglobulin therapy can be used to treat a wide variety of diseases. However, intravenous immunoglobin products can cause several adverse reactions, including hemolysis. The objective of this study was to determine the extent of anemia and hemolysis after high dose intravenous immunoglobin (2 g/kg) and its relationship to the ABO blood type system and hemolytic anemia blood parameters in pediatric patients.